Literature DB >> 28694398

Renal sympathetic denervation assisted treatment of electrical storm due to polymorphic ventricular tachycardia in a patient with cathecolaminergic polymorphic ventricular tachycardia.

Tolga Aksu1, Tümer Erdem Güler, Kazım Serhan Özcan, Serdar Bozyel, Kıvanç Yalın.   

Abstract

Electrical storm (ES) is not a rare clinical entity. Sympathetic hyperactivity may play critical role in development and continuation of ES. Some recent reports have demonstrated that catheter-based renal sympathetic denervation (RSD) may reduce sympathetic activation and have a potential role in reducing arrhythmic burden. A 46-year-old man was admitted to clinic with frequent implantable cardioverter defibrillator shocks and ES related to catecholaminergic polymorphic ventricular tachycardia (VT). Tachycardia was unresponsive to administration of beta-blockers, verapamil, and flecainide. Catheter ablation failed to suppress initial premature ventricular contractions. Based on aggravating effects of sympathetic system in clinical tachycardia, decision was made to perform RSD. After the procedure, sinus rhythm was achieved and no polymorphic VT was detected. Sustained monomorphic VT with right ventricular origin was successfully ablated via endocardial radiofrequency ablation. This new treatment modality may be a potential alternative method for patients in whom other ablative strategies have been unsuccessful.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28694398     DOI: 10.5543/tkda.2017.72773

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  5 in total

1.  A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.

Authors:  Hongyu Duan; Yongyi Lu; Song Yan; Lina Qiao; Yimin Hua; Yifei Li; Kaiyu Zhou; Chuan Wang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

2.  Bilateral cardiac sympathetic denervation in children with long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Murat Akkuş; Yunus Seyrek; Hasan Candaş Kafalı; Yakup Ergül
Journal:  J Electrocardiol       Date:  2020-05-22       Impact factor: 1.438

3.  Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia.

Authors:  Henrik Eckert; Ibrahim El-Battrawy; Michael Veith; Gretje Roterberg; Jacqueline Kowitz; Siegfried Lang; Xiaobo Zhou; Ibrahim Akin; Andreas Mügge; Assem Aweimer
Journal:  J Pers Med       Date:  2022-03-28

4.  Catheter-based renal sympathetic nerve denervation on hypertension management outcomes.

Authors:  Som P Singh; Kevin J Varghese; Fahad M Qureshi; Macy C Anderson; John Foxworth; Mark M Knuepfer
Journal:  World J Radiol       Date:  2022-07-28

Review 5.  Novel approaches for the treatment of ventricular tachycardia.

Authors:  Michael Spartalis; Eleftherios Spartalis; Eleni Tzatzaki; Diamantis I Tsilimigras; Demetrios Moris; Christos Kontogiannis; Efthimios Livanis; Dimitrios C Iliopoulos; Vassilis Voudris; George N Theodorakis
Journal:  World J Cardiol       Date:  2018-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.